{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:40:44Z","timestamp":1792510844484,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008333","name":"University of Alabama at Birmingham","doi-asserted-by":"publisher","award":["T32TR004770"],"award-info":[{"award-number":["T32TR004770"]}],"id":[{"id":"10.13039\/100008333","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.sapharm.2026.10.148","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T06:20:44Z","timestamp":1791786044000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["How are community pharmacist-led health screening services evaluated? A scoping review using the RE-AIM framework"],"prefix":"10.1016","author":[{"given":"Brandy","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8293-9625","authenticated-orcid":false,"given":"Jenna","family":"Honan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-439X","authenticated-orcid":false,"given":"Ibrahim","family":"Alfayoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8991-2361","authenticated-orcid":false,"given":"Adelia","family":"Grabowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Hohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-0895","authenticated-orcid":false,"given":"Lindsey","family":"Hohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.sapharm.2026.10.148_bib1","first-page":"56","article-title":"Advancing public health through community pharmacy practice","volume":"11","author":"DiPietro Mager","year":"2023","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.sapharm.2026.10.148_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ypmed.2018.08.029","article-title":"Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: an umbrella review","volume":"115","author":"San-Juan-Rodriguez","year":"2018","journal-title":"Prev Med"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amepre.2022.04.023","article-title":"Stakeholders' acceptability of pharmacist-led screening in community pharmacies: a systematic review","volume":"63","author":"El-Den","year":"2022","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1715163517745517","article-title":"Pharmacists as accessible primary health care providers: review of the evidence","volume":"151","author":"Tsuyuki","year":"2018","journal-title":"Can Pharm J"},{"issue":"2","key":"10.1016\/j.sapharm.2026.10.148_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.japh.2024.01.004","article-title":"Access to community pharmacies based on drive time and by rurality across the contiguous United States","volume":"64","author":"Sharareh","year":"2024","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/jehp.jehp_1374_20","article-title":"Health-promoting services provided in pharmacies: a systematic review: a systematic review","volume":"10","author":"Shirdel","year":"2021","journal-title":"J Educ Health Promot"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.diabres.2006.06.022","article-title":"Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy","volume":"75","author":"Krass","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091157","article-title":"The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting","volume":"9","author":"Willis","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.sapharm.2026.10.148_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/ijpp.12041","article-title":"Screening for major diseases in community pharmacies: a systematic review: screening for diseases in community pharmacies","volume":"21","author":"Ayorinde","year":"2013","journal-title":"Int J Pharm Pract"},{"issue":"5","key":"10.1016\/j.sapharm.2026.10.148_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2025.102421","article-title":"A cross-sectional look at rural pharmacists' perceptions on implementing a depression screening service in their pharmacies: a brief report","volume":"65","author":"Davis","year":"2025","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"10.1016\/j.sapharm.2026.10.148_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.canep.2015.07.011","article-title":"Promoting the early detection of cancer: a systematic review of community pharmacy-based education and screening interventions","volume":"39","author":"Lindsey","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jac5.1136","article-title":"Community pharmacist patient care services: a systematic review of approaches used for implementation and evaluation","volume":"2","author":"Bacci","year":"2019","journal-title":"J Am Coll Clin Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2024.102272","article-title":"The role of pharmacy in promoting public health: pharmacy and public health in 2050","volume":"65","author":"Strand","year":"2003","journal-title":"J Am Pharm Assoc"},{"issue":"9","key":"10.1016\/j.sapharm.2026.10.148_bib14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am J Public Health"},{"key":"10.1016\/j.sapharm.2026.10.148_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fpubh.2019.00064","article-title":"RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review","volume":"7","author":"Glasgow","year":"2019","journal-title":"Front Public Health"},{"key":"10.1016\/j.sapharm.2026.10.148_bib16","unstructured":"EPIS Framework. EPIS Framework. Accessed September 30, 2025. https:\/\/episframework.com\/."},{"issue":"2","key":"10.1016\/j.sapharm.2026.10.148_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","year":"2011","journal-title":"Adm Policy Ment Health"},{"issue":"6","key":"10.1016\/j.sapharm.2026.10.148_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.puhe.2015.04.001","article-title":"Exposing some important barriers to health care access in the rural USA","volume":"129","author":"Douthit","year":"2015","journal-title":"Public Health"},{"key":"10.1016\/j.sapharm.2026.10.148_bib19","series-title":"Endnote","year":"2013"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"10.1016\/j.sapharm.2026.10.148_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib25","first-page":"285","article-title":"The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"Hong","year":"2018","journal-title":"Educ Inf"},{"key":"10.1016\/j.sapharm.2026.10.148_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106420","article-title":"Role of community pharmacies in a population-based colorectal cancer screening program","volume":"145","author":"Vives","year":"2021","journal-title":"Prev Med: An International Journal Devoted to Practice and Theory"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s11096-016-0303-8","article-title":"Identification of patients with atrial fibrillation in UK community pharmacy: an evaluation of a new service","volume":"38","author":"Twigg","year":"2016","journal-title":"Int J Clin Pharm"},{"issue":"11","key":"10.1016\/j.sapharm.2026.10.148_bib28","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1093\/jac\/dkw264","article-title":"A feasibility service evaluation of screening and treatment of group A streptococcal pharyngitis in community pharmacies","volume":"71","author":"Thornley","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.sapharm.2026.10.148_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18126456","article-title":"Developing an ear health intervention for rural community pharmacy: application of the PRECEDE-PROCEED model","volume":"18","author":"Taylor","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"10.1016\/j.sapharm.2026.10.148_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2024.102152","article-title":"Implementation of a North Dakota opioid misuse and overdose prevention program in West Virginia","volume":"64","author":"Skoy","year":"2003","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.sapharm.2026.10.148_bib30","doi-asserted-by":"crossref","DOI":"10.5888\/pcd19.220028","article-title":"Evaluation of a program to screen patients in community pharmacies for opioid misuse and accidental overdose","volume":"19","author":"Skoy","year":"2022","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.sapharm.2026.10.148_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/ijph.2022.1605386","article-title":"Opportunistic community screening of chronic chagas disease using a rapid diagnosis test in pharmacies in Barcelona (Catalonia, Spain): study protocol and pilot phase results","volume":"67","author":"Silgado","year":"2022","journal-title":"Int J Public Health"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1331\/JAPhA.2013.11176","article-title":"Development, implementation, and evaluation of a pharmacist-conducted screening program for depression","volume":"53","author":"Rosser","year":"2013","journal-title":"J Am Pharm Assoc"},{"issue":"14","key":"10.1016\/j.sapharm.2026.10.148_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19148699","article-title":"Diabetes and cardiovascular diseases risk assessment in community pharmacies: an implementation study","volume":"19","author":"Rondeaux","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"10.1016\/j.sapharm.2026.10.148_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ijpp\/riad055","article-title":"Diabetes risk assessments and HbA1c-measurements in community pharmacies","volume":"31","author":"Risoy","year":"2023","journal-title":"Int J Pharm Pract"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/flgastro-2016-100776","article-title":"A quasi-experimental evaluation of dried blood spot testing through community pharmacies in the tayside region of Scotland","volume":"8","author":"Radley","year":"2017","journal-title":"Frontline Gastroenterol"},{"issue":"2","key":"10.1016\/j.sapharm.2026.10.148_bib72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1331\/JAPhA.2010.09199","article-title":"Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign","volume":"50","author":"Potter","year":"2010","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib73","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1331\/JAPhA.2012.10117","article-title":"Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies","volume":"52","author":"Patwardhan","year":"2012","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.japh.2018.03.003","article-title":"Community pharmacist-directed point-of-care group A streptococcus testing: evaluation of a Canadian program","volume":"58","author":"Papastergiou","year":"2018","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/sextrans-2014-051751","article-title":"Engaging young adult clients of community pharmacies for HIV screening in coastal Kenya: a cross-sectional study","volume":"91","author":"Mugo","year":"2015","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.sapharm.2026.10.148_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1331\/JAPhA.2015.15017","article-title":"Community pharmacists' experience with pharmacogenetic testing","volume":"55","author":"Moaddeb","year":"2015","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"10.1016\/j.sapharm.2026.10.148_bib65","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/inthealth\/ihw023","article-title":"The feasibility and acceptability of screening for hypertension in private drug retail outlets: a pilot study in Mwanza region, Tanzania","volume":"8","author":"Michael","year":"2016","journal-title":"Int Health"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0897190013503970","article-title":"Impact of the fracture risk assessment on patient and physician behavior in osteoporosis prevention","volume":"27","author":"McConaha","year":"2014","journal-title":"J Pharm Pract"},{"issue":"5","key":"10.1016\/j.sapharm.2026.10.148_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijpp.12263","article-title":"Evaluation of a pharmacist-led hypertension preventative and detection service in the Ghanaian community pharmacy: an exploratory study","volume":"24","author":"Marfo","year":"2016","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jac\/dkac358","article-title":"Characteristics of the sore throat test and treat service in community pharmacies (STREP) in Wales: cross-sectional analysis of 11 304 consultations using anonymized electronic pharmacy records","volume":"78","author":"Mantzourani","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/pubmed\/fdv010","article-title":"Towards improving service delivery in screening and intervention services in community pharmacies: a case study of an alcohol IBA service","volume":"38","author":"Mackridge","year":"2016","journal-title":"J Public Health"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1331\/JAPhA.2007.05107","article-title":"Osteoporosis risk screening for women in a community pharmacy","volume":"47","author":"Liu","year":"2007","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2753.2005.00531.x","article-title":"Impact of a community pharmacist-directed clinic in improving screening and awareness of osteoporosis","volume":"11","author":"Law","year":"2005","journal-title":"J Eval Clin Pract"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.puhe.2013.11.001","article-title":"Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service","volume":"128","author":"Krska","year":"2014","journal-title":"Public Health"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.japh.2015.11.008","article-title":"Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness","volume":"56","author":"Klepser","year":"2016","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"10.1016\/j.sapharm.2026.10.148_bib52","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s11096-013-9845-1","article-title":"Alcohol brief intervention in community pharmacies: a feasibility study of outcomes and customer experiences","volume":"35","author":"Khan","year":"2013","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib68","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1186\/s12889-020-08719-0","article-title":"Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study","volume":"20","author":"Kelly","year":"2020","journal-title":"BMC Public Health"},{"issue":"7","key":"10.1016\/j.sapharm.2026.10.148_bib53","first-page":"561","article-title":"Enhancing hypertension awareness and management in the elderly: lessons learned from the airdrie community hypertension awareness and management program (A-CHAMP)","volume":"24","author":"Jones","year":"2008","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1016\/j.sapharm.2026.10.148_bib69","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s11096-023-01596-8","article-title":"Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service","volume":"45","author":"Jeiziner","year":"2023","journal-title":"Int J Clin Pharm"},{"issue":"4S","key":"10.1016\/j.sapharm.2026.10.148_bib54","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.japh.2021.10.032","article-title":"Implementation of a self-measured blood pressure program in a community pharmacy: a pilot study","volume":"62","author":"Jarvis","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"10.1016\/j.sapharm.2026.10.148_bib37","article-title":"Implementation of a health risk assessment into workflow of the appointment-based model at an independent community pharmacy","volume":"10","author":"Jackson","year":"2022","journal-title":"Pharmacy (Basel)"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/pubmed\/fdt017","article-title":"Evaluation of the healthy LifeCheck programme: a vascular risk assessment service for community pharmacies in Leicester city, UK","volume":"35","author":"Hunt","year":"2013","journal-title":"J Public Health"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/pubmed\/fdp092","article-title":"Evaluation of a cardiovascular disease opportunistic risk assessment pilot (\u201cHeart MOT\u201d service) in community pharmacies","volume":"32","author":"Horgan","year":"2010","journal-title":"J Public Health"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib39","article-title":"Development and implementation of an influenza point-of-care testing service in a chain community pharmacy setting","volume":"8","author":"Hardin","year":"2020","journal-title":"Pharmacy (Basel)"},{"issue":"2","key":"10.1016\/j.sapharm.2026.10.148_bib55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1331\/154434504773062609","article-title":"Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from project ImPACT: osteoporosis","volume":"44","author":"Goode","year":"2004","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/nep.13247","article-title":"Evaluation of a chronic kidney disease risk assessment service in community pharmacies","volume":"24","author":"Gheewala","year":"2019","journal-title":"Nephrology"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pec.2011.05.004","article-title":"Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia","volume":"83","author":"Fuller","year":"2011","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.sapharm.2026.10.148_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1874192401509010035","article-title":"Cardiovascular risk assessment and effects on behavior in Switzerland the Swiss heart foundation HerzCheck(R)\/Cardio-Test(R)","volume":"9","author":"Freund","year":"2015","journal-title":"Open Cardiovasc Med J"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.japh.2021.12.003","article-title":"Opioid risk screening: program evaluation from the community pharmacists' perspective","volume":"62","author":"Frenzel","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib42","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.diabres.2015.03.006","article-title":"Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow study","volume":"108","author":"Fikri-Benbrahim","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.sapharm.2026.10.148_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/hiv.12224","article-title":"The rapid test in Spanish pharmacies: a novel programme to reach heterosexual men?","volume":"16","author":"Fernandez-Balbuena","year":"2015","journal-title":"HIV Med"},{"issue":"6","key":"10.1016\/j.sapharm.2026.10.148_bib70","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.sapharm.2018.08.007","article-title":"A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation","volume":"15","author":"Fathima","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1331\/JAPhA.2015.14070","article-title":"Pharmacist-provided rapid HIV testing in two community pharmacies","volume":"55","author":"Darin","year":"2015","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.sapharm.2026.10.148_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1211\/ijpp.16.2.0003","article-title":"Patient responses to an integrated service, initiated by community pharmacists, for the prevention of osteoporosis","volume":"16","author":"Crockett","year":"2008","journal-title":"Int J Pharm Pract"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/0897190017710518","article-title":"Observation of a pharmacist-Conducted group A streptococcal pharyngitis point-of-care test: A time and motion study","volume":"31","author":"Corn","year":"2018","journal-title":"J Pharm Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2026.10.148_bib59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.9745\/GHSP-D-14-00026","article-title":"Evaluation of community-based interventions to improve TB case detection in a rural district of Tanzania","volume":"2","author":"Colvin","year":"2014","journal-title":"Glob Health Sci Pract"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib71","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/00952990.2023.2185891","article-title":"Project lifeline: implementing SBIRT in rural pharmacies to address opioid overdoses and substance use disorder","volume":"49","author":"Cloutier","year":"2023","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib60","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1331\/154434506777069624","article-title":"Community pharmacy-based implementation and evaluation of an osteoporosis self-assessment tool for Asians","volume":"46","author":"Chaiyakunapruk","year":"2006","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.sapharm.2026.10.148_bib61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1331\/1544-3191.44.5.569.Boyle","article-title":"Men's health initiative risk assessment study: effect of community pharmacy-based screening","volume":"44","author":"Boyle","year":"2004","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.sapharm.2026.10.148_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/DMSO.S20649","article-title":"Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton","volume":"4","author":"Bovet","year":"2011","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13012-022-01252-1","article-title":"Evaluation of measures of sustainability and sustainability determinants for use in community, public health, and clinical settings: a systematic review","volume":"17","author":"Hall","year":"2022","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib77","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13012-024-01352-0","article-title":"Navigating the field of implementation science towards maturity: challenges and opportunities","volume":"19","author":"Chambers","year":"2024","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13012-015-0242-0","article-title":"Making sense of implementation theories, models and frameworks","volume":"10","author":"Nilsen","year":"2015","journal-title":"Implement Sci"},{"issue":"mar19 6","key":"10.1016\/j.sapharm.2026.10.148_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1258","article-title":"Process evaluation of complex interventions: Medical research council guidance","volume":"350","author":"Moore","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2026.10.148_bib80","article-title":"A new framework for developing and evaluating complex interventions: update of medical research council guidance","volume":"374","author":"Skivington","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib81","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13012-016-0506-3","article-title":"Implementation, context and complexity","volume":"11","author":"May","year":"2016","journal-title":"Implement Sci"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib82","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/0038038509103208","article-title":"Implementing, embedding, and integrating practices: an outline of normalization process theory","volume":"43","author":"May","year":"2009","journal-title":"Sociology"},{"issue":"4","key":"10.1016\/j.sapharm.2026.10.148_bib83","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.sapharm.2005.09.006","article-title":"Role theory: literature review and implications for patient-pharmacist interactions","volume":"1","author":"Guirguis","year":"2005","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2026.10.148_bib84","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.healthpol.2015.02.007","article-title":"From \u201cretailers\u201d to health care providers: transforming the role of community pharmacists in chronic disease management","volume":"119","author":"Mossialos","year":"2015","journal-title":"Health Policy"},{"issue":"3","key":"10.1016\/j.sapharm.2026.10.148_bib85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.sapharm.2026.10.148_bib86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1748-5908-8-117","article-title":"The dynamic sustainability framework: addressing the paradox of sustainment amid ongoing change","volume":"8","author":"Chambers","year":"2013","journal-title":"Implement Sci"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126003608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126003608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:52:47Z","timestamp":1792507967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741126003608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":83,"alternative-id":["S1551741126003608"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.10.148","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How are community pharmacist-led health screening services evaluated? A scoping review using the RE-AIM framework","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.10.148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}